title: What can we learn from the ZOOM trial?--Authors' reply.
authors.forename: Dino
authors.initials: D
authors.lastname: Amadori
authors.forename: Laura
authors.initials: L
authors.lastname: Mercatali
authors.forename: Oriana
authors.initials: O
authors.lastname: Nanni
authors.forename: Massimo
authors.initials: M
authors.lastname: Aglietta
authors.forename: Barbara
authors.initials: B
authors.lastname: Alessi
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Gianni
authors.forename: Gabriella
authors.initials: G
authors.lastname: Farina
authors.forename: Fernando
authors.initials: F
authors.lastname: Gaion
authors.forename: Francesco
authors.initials: F
authors.lastname: Bertoldo
authors.forename: Daniele
authors.initials: D
authors.lastname: Santini
authors.forename: Roberta
authors.initials: R
authors.lastname: Rondena
authors.forename: Paola
authors.initials: P
authors.lastname: Bogani
authors.forename: Carla Ida
authors.initials: CI
authors.lastname: Ripamonti
authors.forename: Toni
authors.initials: T
authors.lastname: Ibrahim
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles